DK1173440T3 - Tetracycliske azepinoindolforbindelser som 5-HT receptorligander - Google Patents
Tetracycliske azepinoindolforbindelser som 5-HT receptorliganderInfo
- Publication number
- DK1173440T3 DK1173440T3 DK00923532T DK00923532T DK1173440T3 DK 1173440 T3 DK1173440 T3 DK 1173440T3 DK 00923532 T DK00923532 T DK 00923532T DK 00923532 T DK00923532 T DK 00923532T DK 1173440 T3 DK1173440 T3 DK 1173440T3
- Authority
- DK
- Denmark
- Prior art keywords
- azepinoindole
- tetracyclic
- compounds
- receptor ligands
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/16—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Child & Adolescent Psychology (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13081199P | 1999-04-23 | 1999-04-23 | |
EP00923532A EP1173440B1 (en) | 1999-04-23 | 2000-04-20 | Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
PCT/US2000/010600 WO2000064899A1 (en) | 1999-04-23 | 2000-04-20 | Tetracyclic azepinoindole compounds as 5-ht receptor ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1173440T3 true DK1173440T3 (da) | 2004-12-20 |
Family
ID=22446459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00923532T DK1173440T3 (da) | 1999-04-23 | 2000-04-20 | Tetracycliske azepinoindolforbindelser som 5-HT receptorligander |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1173440B1 (es) |
JP (1) | JP2002543080A (es) |
KR (1) | KR20020005708A (es) |
CN (1) | CN1183132C (es) |
AR (1) | AR023574A1 (es) |
AT (1) | ATE276255T1 (es) |
AU (1) | AU760943C (es) |
BR (1) | BR0009983A (es) |
CA (1) | CA2367682A1 (es) |
DE (1) | DE60013803T2 (es) |
DK (1) | DK1173440T3 (es) |
EC (1) | ECSP003426A (es) |
ES (1) | ES2226822T3 (es) |
HK (1) | HK1045512B (es) |
NZ (1) | NZ514553A (es) |
PE (1) | PE20010052A1 (es) |
PT (1) | PT1173440E (es) |
SI (1) | SI1173440T1 (es) |
WO (1) | WO2000064899A1 (es) |
ZA (1) | ZA200108636B (es) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6552017B1 (en) * | 1999-06-15 | 2003-04-22 | Bristol-Myers Squibb Pharma Company | Substituted heterocycle fused gamma-carbolines |
US7071186B2 (en) | 1999-06-15 | 2006-07-04 | Bristol-Myers Squibb Pharma Co. | Substituted heterocycle fused gamma-carbolines |
US6713471B1 (en) | 1999-06-15 | 2004-03-30 | Bristol-Myers Squibb Pharma Company | Substituted heterocycle fused gamma-carbolines |
AU2001269781A1 (en) | 2000-07-06 | 2002-01-21 | Pharmacia And Upjohn Company | Substituted 2,3,7,8,9,10,11,12-octahydroazepino(4,5-b)pyrano(3,2-e) indoles |
US6586421B2 (en) | 2000-09-20 | 2003-07-01 | Pharmacia & Upjohn Company | Substituted azepino[4,5b]indoline derivatives |
AR031202A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados |
AR031200A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados |
AR031199A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados |
US6849619B2 (en) | 2000-12-20 | 2005-02-01 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
MXPA03005438A (es) | 2000-12-20 | 2004-05-05 | Bristol Myers Squibb Co | Pirioindoles substituidos como agonistas y antagonistas de serotonina. |
US20020160999A1 (en) * | 2001-01-08 | 2002-10-31 | Jacobsen Susan Fox | Substituted indolines |
US20030060462A1 (en) * | 2001-08-06 | 2003-03-27 | Hoffman Robert L. | Therapeutic compounds |
WO2003014125A1 (en) * | 2001-08-06 | 2003-02-20 | Pharmacia & Upjohn Company | Therapeutically useful tetracyclic ligands |
AU2002336749A1 (en) * | 2001-09-21 | 2003-04-01 | Pharmacia And Upjohn Company | Tricyclic indole derivatives as 5-ht ligands |
CA2464412A1 (en) * | 2001-10-18 | 2003-04-24 | Pharmacia & Upjohn Company | Tetracyclic azaindoles and -indolines having serotonin 5-ht2cactivity |
TW200307540A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
TWI312781B (en) | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
TW200307682A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
EP1792629A4 (en) | 2004-08-25 | 2010-08-25 | Takeda Pharmaceutical | PREVENTIVE / REMEDY AGENTS FOR INCONTINENCE OF STRESS AND SELECETING METHOD THEREOF |
GT200500317A (es) | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
AU2007207508B2 (en) * | 2006-01-19 | 2011-08-18 | Athersys, Inc. | Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof |
EP2018863B9 (en) | 2006-05-16 | 2015-02-18 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound and use thereof |
JP5567349B2 (ja) | 2007-03-12 | 2014-08-06 | イントラ−セルラー・セラピーズ・インコーポレイテッド | 置換ヘテロ環縮合ガンマ−カルボリンの合成 |
US20100266504A1 (en) | 2007-11-15 | 2010-10-21 | Takahiro Matsumoto | Condensed pyridine derivative and use thereof |
JP5501251B2 (ja) | 2008-01-11 | 2014-05-21 | アルバニー モレキュラー リサーチ, インコーポレイテッド | Mch拮抗薬としての(1−アジノン)置換ピリドインドール類 |
ES2568262T3 (es) * | 2009-04-23 | 2016-04-28 | Abbvie Inc. | Moduladores de receptores de 5-HT y sus métodos de uso |
WO2011003012A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
WO2011003007A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
EP2448585B1 (en) | 2009-07-01 | 2014-01-01 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof |
US9073925B2 (en) | 2009-07-01 | 2015-07-07 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
JPWO2011071136A1 (ja) | 2009-12-11 | 2013-04-22 | アステラス製薬株式会社 | 線維筋痛症治療剤 |
US8993765B2 (en) | 2010-12-21 | 2015-03-31 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof |
US8697700B2 (en) | 2010-12-21 | 2014-04-15 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof |
ES2727815T3 (es) | 2012-04-14 | 2019-10-18 | Intra Cellular Therapies Inc | Tratamiento del TEPT y de trastornos del control de impulsos |
EP2968320B1 (en) | 2013-03-15 | 2020-11-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
KR102495941B1 (ko) | 2013-12-03 | 2023-02-06 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규한 방법 |
BR112016023162B1 (pt) | 2014-04-04 | 2022-11-29 | Intra-Cellular Therapies, Inc | Compostos orgânicos gama-carbolinas, composições farmacêuticas compreendendo os ditos compostos e uso dos mesmos no tratamento ou na profilaxia de transtornos de sistema nervoso central |
MX2016013046A (es) | 2014-04-04 | 2017-02-15 | Intra-Cellular Therapies Inc | Compuestos organicos. |
BR112018015283B1 (pt) | 2016-01-26 | 2023-09-26 | Intra-Cellular Therapies, Inc | Compostos orgânicos, composição farmacêutica compreendendo os ditos compostos e uso dos mesmos para o tratamento ou profilaxia de um distúrbio do sistema nervoso central |
WO2017172795A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
EP3436016B1 (en) | 2016-03-28 | 2022-04-27 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
EP3436455A4 (en) | 2016-03-28 | 2019-09-04 | Intra-Cellular Therapies, Inc. | NOVEL SALTS AND CRYSTALS |
CN105837571A (zh) * | 2016-04-23 | 2016-08-10 | 何华琼 | 盐酸倍他司汀的药物组合物及其在生物医药中的应用 |
US11331316B2 (en) | 2016-10-12 | 2022-05-17 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
WO2018126143A1 (en) | 2016-12-29 | 2018-07-05 | Intra-Cellular Therapies, Inc. | Organic compounds |
US10961245B2 (en) | 2016-12-29 | 2021-03-30 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders |
CA3054841A1 (en) | 2017-03-24 | 2018-09-27 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
WO2019023063A1 (en) | 2017-07-26 | 2019-01-31 | Intra-Cellular Therapies, Inc. | ORGANIC COMPOUNDS |
MX2020000968A (es) | 2017-07-26 | 2020-09-28 | Intra Cellular Therapies Inc | Compuestos organicos. |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
JP7483671B2 (ja) | 2018-06-11 | 2024-05-15 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 置換ヘテロ環縮合ガンマ-カルボリン類合成 |
EP3843738A4 (en) | 2018-08-31 | 2022-06-01 | Intra-Cellular Therapies, Inc. | NEW METHODS |
WO2020047408A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
BR112021016620A2 (pt) | 2019-02-27 | 2021-11-03 | Univ California | Azepino-indóis e outros heterociclos para o tratamento de distúrbios cerebrais |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3839357A (en) * | 1966-05-10 | 1974-10-01 | Upjohn Co | 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles |
US3676558A (en) * | 1970-08-28 | 1972-07-11 | Upjohn Co | Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment |
EP0377238A1 (en) * | 1988-12-22 | 1990-07-11 | Duphar International Research B.V | New annelated indolo (3,2-c)-lactams |
-
2000
- 2000-04-19 AR ARP000101881A patent/AR023574A1/es unknown
- 2000-04-19 PE PE2000000368A patent/PE20010052A1/es not_active Application Discontinuation
- 2000-04-20 CN CNB008066639A patent/CN1183132C/zh not_active Expired - Fee Related
- 2000-04-20 SI SI200030516T patent/SI1173440T1/xx unknown
- 2000-04-20 AT AT00923532T patent/ATE276255T1/de not_active IP Right Cessation
- 2000-04-20 BR BR0009983-0A patent/BR0009983A/pt not_active IP Right Cessation
- 2000-04-20 AU AU43637/00A patent/AU760943C/en not_active Ceased
- 2000-04-20 ES ES00923532T patent/ES2226822T3/es not_active Expired - Lifetime
- 2000-04-20 NZ NZ514553A patent/NZ514553A/en unknown
- 2000-04-20 EP EP00923532A patent/EP1173440B1/en not_active Expired - Lifetime
- 2000-04-20 KR KR1020017013458A patent/KR20020005708A/ko not_active Application Discontinuation
- 2000-04-20 JP JP2000614251A patent/JP2002543080A/ja active Pending
- 2000-04-20 PT PT00923532T patent/PT1173440E/pt unknown
- 2000-04-20 DE DE60013803T patent/DE60013803T2/de not_active Expired - Fee Related
- 2000-04-20 WO PCT/US2000/010600 patent/WO2000064899A1/en not_active Application Discontinuation
- 2000-04-20 DK DK00923532T patent/DK1173440T3/da active
- 2000-04-20 CA CA002367682A patent/CA2367682A1/en not_active Abandoned
- 2000-04-27 EC EC2000003426A patent/ECSP003426A/es unknown
-
2001
- 2001-10-19 ZA ZA200108636A patent/ZA200108636B/en unknown
-
2002
- 2002-09-26 HK HK02107016.3A patent/HK1045512B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU760943C (en) | 2003-12-04 |
BR0009983A (pt) | 2002-04-16 |
CA2367682A1 (en) | 2000-11-02 |
KR20020005708A (ko) | 2002-01-17 |
ECSP003426A (es) | 2000-10-24 |
CN1348454A (zh) | 2002-05-08 |
AU760943B2 (en) | 2003-05-22 |
AR023574A1 (es) | 2002-09-04 |
WO2000064899A1 (en) | 2000-11-02 |
DE60013803T2 (de) | 2005-11-17 |
PE20010052A1 (es) | 2001-01-27 |
HK1045512A1 (en) | 2004-10-15 |
ES2226822T3 (es) | 2005-04-01 |
DE60013803D1 (de) | 2004-10-21 |
ATE276255T1 (de) | 2004-10-15 |
NZ514553A (en) | 2003-10-31 |
HK1045512B (zh) | 2005-09-02 |
CN1183132C (zh) | 2005-01-05 |
SI1173440T1 (en) | 2005-02-28 |
AU4363700A (en) | 2000-11-10 |
ZA200108636B (en) | 2003-02-19 |
EP1173440B1 (en) | 2004-09-15 |
EP1173440A1 (en) | 2002-01-23 |
JP2002543080A (ja) | 2002-12-17 |
PT1173440E (pt) | 2004-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1173440T3 (da) | Tetracycliske azepinoindolforbindelser som 5-HT receptorligander | |
ATE253067T1 (de) | Diazabicyloderivate als nikotin-acetylcholin- rezeptorliganden | |
NO20013671D0 (no) | Substituerte bicycliske derivater nyttige som anticancer midler | |
DK1414440T3 (da) | N-phenylpyrrolguanidinderivater som melanocortinreceptorligander | |
IS6267A (is) | Ný spíróefnasambönd | |
DK1102762T3 (da) | 2-substituerede-1-piperidylbenzimidazolforbindelser som ORL1-receptoragonister | |
MA25403A1 (fr) | Ligandes de recepteur de melanocortine | |
IS6239A (is) | Ný efnasambönd | |
NO20013909L (no) | Heteroaryl-substituerte kinolin-2-on derivater nyttige som anticancer midler | |
IL154310A0 (en) | Heterocyclic compounds as ligands of the gabaa receptor | |
ATE305470T1 (de) | Naphthyridinverbindungen | |
DK1355900T3 (da) | Heterocyclylalkylindol- eller -azaindolforbindelser som 5-hydroxytryptamin-6-ligander | |
IS6139A (is) | Ný efnasambönd | |
NO20013997D0 (no) | Reseptoranalyse | |
NO20021251D0 (no) | Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister | |
NO20042294L (no) | Heteroarylderivater som overlegne ligander for nociceptinreseptor ORL-1 | |
DK1560828T3 (da) | Imidazoquinolinderivater som adenosin-A3-receptorligander | |
DK1347974T3 (da) | Aminotriazolopyridinderivater som adenosinreceptorligander | |
AU2001259051A1 (en) | Piperidyindoles as serotonin receptor ligands | |
DK1155000T3 (da) | 2-aminopyridiner som indeholder sammensluttede ringsubstituenser | |
DK1467998T3 (da) | Tetracykliske hetaroforbindelser som östrogenreceptormodulatorer | |
IS6141A (is) | Ný efnasambönd | |
DK1380585T3 (da) | Pyrazolopyridinon som mellemprodukt | |
IT1303260B1 (it) | Procedimento per preparare composti indolici. | |
AU2002332480A1 (en) | Tetracyclic indole derivatives as 5-ht receptor ligands |